MedTrace Logo

To Evaluate the Efficacy and Safety of DW-1401 in Acute and Chronic Gastritis Patients

NCT03443804 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 462

Last updated 2018-02-28

No results posted yet for this study

Summary

Evaluate the Efficacy and Safety of DW1401 versus Stillen tab. in Patients with Acute or Chronic Gastritis

Conditions

  • Gastritis Acute
  • Gastritis Chronic

Interventions

DRUG

Test(DW1401)

DW1401+Placebo of Stillen tab.

DRUG

Reference(Stillen tab.)

Stillen tab.+Placebo of DW1401

Sponsors & Collaborators

  • Daewon Pharmaceutical Co., Ltd.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-07-31
Primary Completion
2014-11-30
Completion
2014-11-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03443804 on ClinicalTrials.gov